An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan, Improves Insulin Resistance in KK-Ay Diabetic Mice

Journal Title: International Journal of Biomedical Science (IJBS) - Year 2006, Vol 2, Issue 4

Abstract

Metabolic syndrome is strongly associated with insulin resistance and consists of a constellation of factors such as hypertension and hyperlipidemia that raise the risk for cardiovascular diseases and diabetes mellitus. The renin-angiotensin system (RAS) plays a pivotal role in the pathogenesis of diabetes and cardiovascular disease (CVD) in hypertensive patients. Further, recently, the interruption of the RAS has been shown to prevent the onset of diabetes in hypertensive patients. However, whether telmisartan, an angiotensin II type 1 receptor blocker (ARB) with selective peroxisome proliferator-activated receptor-γ (PPAR-γ) agonistic property could improve insulin sensitivity is not fully understood. In this study, we studied the effects of telmisartan on insulin sensitivity in KK-Ay mice, an obese type 2 diabetic animal. Although there was no significant difference in body weight, food consumption, and glucose levels between the two groups, plasma insulin, triglycerides and non-esterified fatty acid levels were significantly decreased in telmisartan-treated KK-Ay mice, compared with control KK-Ay mice. The present findings suggest that telmisartan could exert a beneficial effect on insulin sensitivity in diabetic animals. Inhibition of the RAS by telmisartan, a selective agonist of PPAR-γ, may become a promising strategy for the treatment of hypertensive patients with metabolic syndrome and/or insulin resistance. How to cite this article: Int. J. Biomed. Sci. 2006; 2(4):333-336 For full text article or PDF file, visit: www.ijbs.org

Authors and Affiliations

Toshiyuki Takasu, Hirotoshi Kakuta, Masao Sasamata, Sho-ichi Yamagishi

Keywords

Related Articles

Biomaterials in Maxillofacial Surgery: Membranes and Grafts

Today, significant differences in the use of biomaterials (membranes and grafts) of animal or synthetic origin have yet to be reported. Nevertheless, some evidences suggest that synthetic materials have a lower risk of d...

An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan, Improves Insulin Resistance in KK-Ay Diabetic Mice

Metabolic syndrome is strongly associated with insulin resistance and consists of a constellation of factors such as hypertension and hyperlipidemia that raise the risk for cardiovascular diseases and diabetes mellitus....

Haplotype based association study between t-PA gene and essential hypertension

Several previous studies have shown that essential hypertension (EH) is associated with fibrinolysis. Tissue plasminogen activator (t-PA) plays a key role in fibrinolysis. Thus, it is possible that the t-PA gene is a sus...

Retroperitoneal Hemorrhage from Adrenocortical Carcinoma as a Poor Prognostic Factor

In most patients, adrenocortical carcinoma is diagnosed at an advanced stage of the disease. A sudden retroperitoneal hemorrhage may sometimes be the first symptom of the adrenal cancer. We describe four patients with ad...

Free Radicals, Antioxidants in Disease and Health

Free radicals and oxidants play a dual role as both toxic and beneficial compounds, since they can be either harmful or helpful to the body. They are produced either from normal cell metabolisms in situ or from external...

Download PDF file
  • EP ID EP83938
  • DOI -
  • Views 98
  • Downloads 0

How To Cite

Toshiyuki Takasu, Hirotoshi Kakuta, Masao Sasamata, Sho-ichi Yamagishi (2006). An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan, Improves Insulin Resistance in KK-Ay Diabetic Mice. International Journal of Biomedical Science (IJBS), 2(4), 333-336. https://europub.co.uk/articles/-A-83938